Financial & Policy Research Insights

CFRA’s latest stock report on UnitedHealth Group ($UNH) outlines a sharp downgrade to Sell amid DOJ fraud investigations and reduced earnings guidance.

This report examines the deceleration of the private equity flywheel, highlighting the downstream effects on ALT firm monetization, fundraising, and exit strategies in 2025.

This report analyzes the market impact of Moody's U.S. credit downgrade, rising national debt, and the looming wave of Treasury issuance.

Temporary tariff cuts ease pressure on U.S. retailers, but inflation and supply chain challenges remain.

This report reveals the automakers gaining ground in global markets and those at risk of falling further behind, with implications for long-term performance and equity positioning.

Why New State Legislation Could Upend Business Models for CTRE, MPW, OHI, SBRA, and WELL.

Explore CFRA’s deep-dive on how Rocket Lab is redefining satellite launch economics and end-to-end space systems.

In the first 100 days of the Trump administration, healthcare has shifted...

Get actionable insights into trade disputes, healthcare reform, defense funding, tech regulation, and energy market shifts with Washington Analysis’ comprehensive Q2 2025 outlook.

Get exclusive insights into the lawsuits challenging IEEPA tariffs and what’s next for U.S. trade policy and markets.